Whereas M1R and M3R expression was similar in a normal colon and the expression of both receptor subtypes increased equally in ACF, the ratio of M3R to M1R expression was significantly enhanced in adenomas and primary colon cancers. Here, CHRM1 is linked to malignant colon neoplasm.